Iatrogenic Ocular Surface Diseases Occurring during and/or after Different Treatments for Ocular Tumours
نویسندگان
چکیده
منابع مشابه
Preface: A focus on new treatments for blinding ocular diseases.
This publication presents results from a workshop held June 11 to 13, 2011, in Rancho Valencia, California, entitled “An Eye on Glaucoma: New Opportunities for Treatment.” The purpose of the workshop was to gather a small group of experts in the glaucoma field and, in an informal setting, pinpoint the key needs and opportunities for preventing, treating, and ultimately curing glaucoma. For the ...
متن کاملIntra-ocular Tumours.
IN practice, intra-ocular tumours are vaguely classified as gliomata if they originate in the retina, or as melanomata if they have originated in the choroid and contain brown pigment that does not give the iron reaction. Those attempting greater precision place most of the gliomata in the more restricted group of retinoblastomata. The problem, however, is not so simple, for on closer examinati...
متن کامل[Keratoprosthesis in cornea and ocular surface diseases].
In 1771, Guillaume Pellier de Quengsy,1 an ophthalmologist, proposed for the first time the possibility of substituting opacifie corneal tissue by “an artificial cornea”. The proposal was for transparent glass plates to substitute the opaque cornea in order to enhance the transparency of optic media. Improvements in topical and systemic immunosuppression and limbus transplant techniques for tre...
متن کاملInvestigating Ocular Diseases in Patients with Psoriasis
Background and purpose: Psoriasis is an inflammatory disease with skin and joint manifestations. This disease can be associated with ocular complications and reduce vision and quality of life. The aim of this study was to determine the prevalence and type of ocular involvement in patients with psoriasis to prevent unwanted complications by identifying the disease at the right time. Materials a...
متن کاملMesenchymal stem cells for treating ocular surface diseases
Mesenchymal stem cells (MSC) have become a promising tool for cell therapy in regenerative medicine. They are readily available, demonstrate powerful differentiation capabilities and present immunosuppressive properties that aid them in surviving from host immune rejection for its great potential use in allograft. Currently clinical trials are underway using MSC, both culture-expanded allogenei...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancers
سال: 2021
ISSN: 2072-6694
DOI: 10.3390/cancers13081933